Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quality of Life

Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation

Abstract

We assessed long-term outcome in 155 patients who had undergone an allogeneic/syngeneic stem cell transplant (SCT) and were in complete remission for more than 2 years after transplant. Probability of late transplant-related mortality was 6%, and affected only patients with chronic graft-versus-host disease (cGVHD). Thirteen percent of patients experienced relapse. Overall survival projected at 10 and 15 years was 83% and 76%, respectively. Secondary malignancies occurred in two patients, 7.5 and 11 years after SCT. Three female and four male patients parented children 19 to 84 months after SCT. Quality of life (QoL) was assessed in a cross-sectional study by the means of a 30-item questionnaire (QLQ-C30) of the EORTC. The questionnaire was sent to 127 patients remaining alive and answered by 106 patients. Seventy-three percent reported a good to very good QoL within 5 years after SCT and 78% after this time point. However, patients with cGVHD had significant impairment of physical, role and social functioning and only 60% of them were fit for work. These results from long-term survivors show that high cure rates with good to very good QoL can be achieved by allogeneic or syngeneic SCT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. O'Donnell MR, Nademanee AP, Snyder DS et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes J Clin Oncol 1987 5: 1822 1826

    Article  CAS  PubMed  Google Scholar 

  2. Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma New Engl J Med 1991 325: 1267 1273

    Article  CAS  PubMed  Google Scholar 

  3. Clift RA, Appelbaum FR, Thomas ED . Treatment of chronic myeloid leukemia by bone marrow transplantation Blood 1993 82: 1954 1956

    CAS  PubMed  Google Scholar 

  4. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia New Engl J Med 1995 332: 217 223

    Article  CAS  PubMed  Google Scholar 

  5. Passweg JR, Socié G, Hinterberger W et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997 90: 858 864

    CAS  PubMed  Google Scholar 

  6. de Witte T, Hermans J, Vossen J et al. Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol 2000 110: 620 630

    Article  CAS  PubMed  Google Scholar 

  7. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann Intern Med 1988 108: 806 814

    Article  CAS  PubMed  Google Scholar 

  8. Appelbaum FR . The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation Semin Oncol 1993 20: (Suppl. 4) 3 10

    CAS  PubMed  Google Scholar 

  9. Tutschka PJ . Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting Bone Marrow Transplant 1993 12: (Suppl. 1) 34 36

    PubMed  Google Scholar 

  10. Boeckh M, Bowden RA, Gooley T et al. Successful modification of a pp65 antigenemia based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients Blood 1999 93: 1781 1782

    CAS  PubMed  Google Scholar 

  11. Roy V, Ochs L, Weisdorf D . Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis Leuk Lymphoma 1997 26: 1 15

    Article  CAS  PubMed  Google Scholar 

  12. Winston DJ, Gale RP . Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s Bone Marrow Transplant 1991 8: 7 11

    CAS  PubMed  Google Scholar 

  13. Fischer GF, Faé I, Petrasek M, Moser S . A combination of two distinct in vitro amplification procedures for DNA typing of HLA-DRB and -DQB1 alleles Vox Sang 1995 69: 328 335

    CAS  PubMed  Google Scholar 

  14. Greinix HT, Volc-Platzer B, Knobler RM . Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease Leuk Lymphoma 2000 36: 425 434

    Article  CAS  PubMed  Google Scholar 

  15. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for acute leukemia New Engl J Med 1986 314: 729 735

    Article  CAS  PubMed  Google Scholar 

  16. Frassoni F, Labopin M, Gluckman E et al. Are patients with acute leukemia, alive and well 2 years post bone marrow transplantation cured? A European survey Leukemia 1994 8: 924 928

    CAS  PubMed  Google Scholar 

  17. Singhal S, Powles R, Treleaven J et al. Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling Leuk Lymphoma 1999 34: 287 294

    Article  CAS  PubMed  Google Scholar 

  18. Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients Blood 1996 87: 386 392

    CAS  PubMed  Google Scholar 

  19. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation New Engl J Med 1997 336: 897 904

    Article  CAS  PubMed  Google Scholar 

  20. Sutherland HJ, Fyles GM, Adams G et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms Bone Marrow Transplant 1997 19: 1129 1136

    Article  CAS  PubMed  Google Scholar 

  21. Hjermstad MJ, Holte H, Evensen SA et al. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant 1999 24: 911 918

    Article  CAS  PubMed  Google Scholar 

  22. Chiodi S, Spinelli S, Ravera G et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation Br J Haematol 2000 110: 614 619

    Article  CAS  PubMed  Google Scholar 

  23. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation New Engl J Med 1975 292: 832 843 895 902

    Article  CAS  PubMed  Google Scholar 

  24. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression Blood 1981 57: 267 276

    CAS  PubMed  Google Scholar 

  25. Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease Blood 1988 72: 555 561

    CAS  PubMed  Google Scholar 

  26. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 1993 85: 365 376

    Article  CAS  PubMed  Google Scholar 

  27. Bush NE, Haberman M, Donaldson G, Sullivan KM . Quality of life of 125 adults surviving 6–8 years after bone marrow transplantation Soc Sci Med 1995 40: 479 490

    Article  CAS  PubMed  Google Scholar 

  28. Rabitsch W, Deviatko E, Keil F et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation Transplantation 2001 71: 1341 1343

    Article  CAS  PubMed  Google Scholar 

  29. Gmeinhart B, Hinterberger W, Greinix HT et al. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD) Bone Marrow Transplant 1999 11: 1197 1199

    Article  Google Scholar 

  30. Reiter E, Greinix HT, Keil F et al. Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia Ann Hematol 1999 78: 507 513

    Article  CAS  PubMed  Google Scholar 

  31. Hinterberger-Fischer M, Kier P, Kalhs P et al. Fertility, pregnancies and offspring complications after bone marrow transplantation Bone Marrow Transplant 1991 7: 5 9

    CAS  PubMed  Google Scholar 

  32. Witherspoon R, Flournoy N, Thomas ED et al. Recurrence of acute leukemia more than two years after allogeneic marrow grafting Exp Hematol 1986 14: 178 181

    CAS  PubMed  Google Scholar 

  33. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1996 86: 2041 2050

    Google Scholar 

  34. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood 1996 87: 3045 3052

    CAS  PubMed  Google Scholar 

  35. Syrjala KL, Chapko MK, Vitaliano PP et al. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning Bone Marrow Transplant 1993 11: 319 327

    CAS  PubMed  Google Scholar 

  36. Andrykowski MA, Brady MJ, Greiner CB et al. ‘Returning to normal’ following bone marrow transplantation: outcomes, expectations and informed consent Bone Marrow Transplant 1995 15: 573 581

    CAS  PubMed  Google Scholar 

  37. Duell T, Van Lint MT, Ljungman P et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT working party on late effects and EULEP study group on late effects. European group for blood and marrow transplantation Ann Intern Med 1997 126: 184 192

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the nurses, fellows and house staff and the medical technicians of our stem cell transplant program, Department of Blood Group Serology and Transfusion Medicine and Department for Radiotherapy and the physicians who referred patients to our unit.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Worel, N., Biener, D., Kalhs, P. et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30, 619–626 (2002). https://doi.org/10.1038/sj.bmt.1703677

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703677

Keywords

This article is cited by

Search

Quick links